ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 233 filers reported holding ROYALTY PHARMA PLC in Q3 2021. The put-call ratio across all filers is 0.36 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,159,455 | -13.3% | 595,411 | -1.8% | 0.02% | -3.8% |
| Q2 2023 | $18,637,416 | -12.7% | 606,292 | +2.3% | 0.03% | -18.8% |
| Q1 2023 | $21,345,289 | -9.2% | 592,431 | -0.5% | 0.03% | -13.5% |
| Q4 2022 | $23,519,024 | +0.2% | 595,117 | +1.9% | 0.04% | -7.5% |
| Q3 2022 | $23,467,000 | -5.2% | 584,051 | -0.8% | 0.04% | +2.6% |
| Q2 2022 | $24,751,000 | +12.1% | 588,755 | +3.9% | 0.04% | +34.5% |
| Q1 2022 | $22,070,000 | -7.2% | 566,475 | -5.1% | 0.03% | +3.6% |
| Q4 2021 | $23,785,000 | +50.5% | 596,869 | +36.5% | 0.03% | +40.0% |
| Q3 2021 | $15,800,000 | -32.5% | 437,188 | -23.5% | 0.02% | -31.0% |
| Q2 2021 | $23,421,000 | -6.5% | 571,384 | -0.5% | 0.03% | -12.1% |
| Q1 2021 | $25,049,000 | +153.6% | 574,260 | +191.0% | 0.03% | +135.7% |
| Q4 2020 | $9,879,000 | +58.9% | 197,373 | +33.5% | 0.01% | +40.0% |
| Q3 2020 | $6,219,000 | – | 147,831 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |